These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17961403)

  • 1. [A clinical study on the significance of airway hyperresponsiveness monitoring in the adjustment of combined therapy for asthmatic patients].
    Liu CT; Wang YM; Wang G; Tan CW; Pang YM
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jul; 30(7):498-503. PubMed ID: 17961403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on the relevance of airway inflammatory indices in induced sputum and airway hyperresponsiveness in asthmatics].
    Pang YM; Liu CT; Tan CW; Wang G
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):591-5. PubMed ID: 17129464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The long term effect of small dose budesonide turbuhaler on mild bronchial asthma].
    Weng JL; Zheng YS; Ma QF
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):88-92. PubMed ID: 15854388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial.
    Nuijsink M; Hop WC; Sterk PJ; Duiverman EJ; de Jongste JC
    Eur Respir J; 2007 Sep; 30(3):457-66. PubMed ID: 17537770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.
    Lundbäck B; Rönmark E; Lindberg A; Jonsson AC; Larsson LG; Pétavy F; James M
    Respir Med; 2006 Jan; 100(1):2-10. PubMed ID: 16243498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of salmeterol (50 microgram) and fluticasone (250 microgram) in a single inhaler device (diskus) in patients with mild to moderate asthma].
    Beeh KM; Beier J; Kornmann O; Wiewrodt R; Buhl R;
    Pneumologie; 2002 Feb; 56(2):91-7. PubMed ID: 11842346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
    Jiang YW; Sun YC; Zhou QT; Gai XY; Cao WL; Yao WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
    den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C
    Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.
    Koopmans JG; Lutter R; Jansen HM; van der Zee JS
    Thorax; 2006 Apr; 61(4):306-12. PubMed ID: 16449264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluticasone for the treatment of symptomatic bronchial asthma in children treated with sodium cromogylate--a prospective, randomised trial.
    von Berg A; Gappa M; Steinkamp G;
    Eur J Med Res; 2002 Jun; 7(6):257-64. PubMed ID: 12117660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
    Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthmatics able to step down from inhaled corticosteroid treatment without loss of asthma control have low serum eotaxin/CCL11.
    Hoffmann HJ; Nielsen LP; Harving H; Heinig JH; Dahl R
    Clin Respir J; 2008 Jul; 2(3):149-57. PubMed ID: 20298323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.